S. Lizard

发表

Comparative Genotyping of Candida albicans Bloodstream and Nonbloodstream Isolates at a Polymorphic Microsatellite Locus

F. Dalle, A. Bonnin, S. Aho, 2000, Journal of Clinical Microbiology.

Phase I / II study of neoadjuvant bevacizumab , erlotinib and 5-fl uorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

I. Bièche, J. Solassol, H. Blons, 2013 .

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

I. Bièche, J. Solassol, H. Blons, 2013 .

Rare epidermal growth factor receptor (EGFR) mutations in 10,117 patients with non-small cell lung cancer (NSCLC) evaluated by the French ERMETIC IFCT network: Clinical, molecular, and survival data.

J. Solassol, H. Blons, F. Escande, 2012 .

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

F. Révillion, Chloé-Agathe Azencott, N. Sevenet, 2020, BMC Medical Research Methodology.

Genotyping of Candida albicans Oral Strains from Healthy Individuals by Polymorphic Microsatellite Locus Analysis

F. Dalle, A. Bonnin, D. Caillot, 2003, Journal of Clinical Microbiology.

11q13 Amplification in local recurrence of human primary breast cancer

I. Bièche, R. Lidereau, M. Champème, 1995, Genes, chromosomes & cancer.

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms.

J. Pignon, J. Mosser, I. Bièche, 2014, The Journal of molecular diagnostics : JMD.

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

F. Révillion, R. Lidereau, N. Sevenet, 2021, American journal of human genetics.

Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12).

J. Thiery, A. Aurias, C. Turc‐Carel, 1988, Cancer genetics and cytogenetics.

Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12

F. Révillion, D. Stoppa-Lyonnet, C. Houdayer, 2020, Cancer Research.

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.

J-L Pretet, I. Bièche, J. Solassol, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16).

A. Aurias, C. Turc‐Carel, F. Mugneret, 1988, Cancer genetics and cytogenetics.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases

L. Xerri, A. Salomon, B. Esterni, 2013, BMC Cancer.

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

C. Coutant, N. Sevenet, C. Lepage, 2016, Oncotarget.

Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2).

J. Pignon, H. Blons, G. Zalcman, 2019, Clinical lung cancer.

BRCA Share: A Collection of Clinical BRCA Gene Variants

Christophe Béroud, Dominique Vaur, Izabela Karbassi, 2016, Human mutation.

Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene

C. Coutant, C. Lepage, T. Frebourg, 2013, European Journal of Human Genetics.

[CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3].

C. Coutant, P. Fumoleau, V. Lorgis, 2016, Bulletin du cancer.

[Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer].

C. Coutant, P. Fumoleau, V. Lorgis, 2015, Bulletin du cancer.

Identification and validation of a factor of commutability between platelet counts performed on EDTA and citrate.

P. Dumont, J. Riedinger, A. David, 2017, Annales de biologie clinique.

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Jane E. Carpenter, W. Chung, M. Beckmann, 2019, npj Breast Cancer.